Recombinant Protein & Peptide Therapeutics

Development and application of therapeutic proteins or peptides produced through recombinant DNA technology, including fusion proteins and modified growth factors.

9,324 US filings from 3,584 companies since 2023 · 2023: 2,612 · 2024: 2,906 · 2025: 2,641 · 2026 YTD: 1,165

Therapeutic Activity (Pharma)

Top companies

Ranked by filings in this theme since 2023. 2026 is partial.

#	Company	Since 2023	2023	2024	2025	2026 YTD	YoY
1	Immatics Biotechnologies GmbH	329	140	130	54	5	-58.5%
2	Regeneron Pharmaceuticals, Inc.	104	27	39	31	7	-20.5%
3	The Regents of the University of California	84	19	29	17	19	-41.4%
4	Genentech, Inc.	74	19	31	16	8	-48.4%
5	Chugai Seiyaku Kabushiki Kaisha	69	19	18	19	13	+5.6%
6	AMGEN INC.	67	17	19	21	10	+10.5%
7	BicycleTx Limited	59	18	17	16	8	-5.9%
8	Codexis, Inc.	54	13	19	19	3	0.0%
9	The Board of Trustees of the Leland Stanford Junior University	52	15	16	18	3	+12.5%
10	Sanofi	48	12	17	17	2	0.0%
11	CAREGEN CO., LTD.	45	7	14	18	6	+28.6%
12	ELI LILLY AND COMPANY	43	4	12	18	9	+50.0%
13	Wyvern Pharmaceuticals Inc.	42	·	1	29	12	+2800.0%
14	Northwestern University	38	4	18	8	8	-55.6%
15	BIOVERATIV THERAPEUTICS INC.	37	13	10	10	4	0.0%
16	Hoffmann-La Roche Inc.	37	10	7	10	10	+42.9%
17	Ohio State Innovation Foundation	37	9	13	4	11	-69.2%
18	UNIVERSITY OF WASHINGTON	36	12	9	13	2	+44.4%
19	Acceleron Pharma Inc.	35	7	12	14	2	+16.7%
20	Halozyme, Inc.	35	7	17	10	1	-41.2%
21	NOVO NORDISK A/S	35	12	12	7	4	-41.7%
22	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED	35	9	11	11	4	0.0%
23	Novartis AG	34	11	12	7	4	-41.7%
24	Board of Regents, The University of Texas System	33	10	7	13	3	+85.7%
25	Ablynx N.V.	33	7	14	8	4	-42.9%